Cranbrook Wealth Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Hold
550
0.04% 120
2026
Q1
$118K Hold
550
0.02% 149
2025
Q4
$94.1K Hold
550
0.02% 172
2025
Q3
$73.6K Hold
550
0.01% 181
2025
Q2
$53.5K Hold
550
0.01% 195
2025
Q1
$40K Hold
550
0.01% 199
2024
Q4
$39.7K Hold
550
0.01% 199
2024
Q3
$44.9K Hold
550
0.01% 192
2024
Q2
$58.6K Hold
550
0.01% 167
2024
Q1
$53.4K Hold
550
0.01% 155
2023
Q4
$43.1K Hold
550
0.01% 164
2023
Q3
$34.5K Hold
550
0.01% 169
2023
Q2
$35.4K Hold
550
0.01% 172
2023
Q1
$29.2K Buy
550
+450
+450% +$22.1K 0.01% 178
2022
Q4
$4.2K Hold
100
﹤0.01% 256
2022
Q3
$4K Hold
100
﹤0.01% 274
2022
Q2
$4K Sell
100
-1,320
-93% -$62.8K ﹤0.01% 275
2022
Q1
$76K Hold
1,420
0.02% 149
2021
Q4
$102K Hold
1,420
0.02% 129
2021
Q3
$81K Buy
1,420
+100
+8% +$6.08K 0.02% 150
2021
Q2
$86K Sell
1,320
-60
-4% -$3.79K 0.02% 140
2021
Q1
$82K Buy
+1,380
New +$75.2K 0.02% 145

Other funds holding LRCX

Cranbrook Wealth Management's LRCX Position: Q2 2026 in Review

Cranbrook Wealth Management held its Lam Research (LRCX) position steady in Q2 2026 at 550 shares worth $238K. The position accounts for 0.04% of the portfolio, ranked #120.

Cranbrook Wealth Management first reported a position in LRCX in Q1 2021 and has held it in 22 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Cranbrook Wealth Management held 550 shares of Lam Research worth $238K as of Q2 2026.
  • Cranbrook Wealth Management left its Lam Research share count unchanged in Q2 2026.
  • Lam Research made up 0.04% of Cranbrook Wealth Management's portfolio in Q2 2026, its #120 holding.
  • Cranbrook Wealth Management first reported a position in Lam Research in Q1 2021 and has held it in 22 quarters since.
  • 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.